Skip to main content
Journal of Clinical Orthopaedics and Trauma logoLink to Journal of Clinical Orthopaedics and Trauma
. 2018 Apr 22;9(Suppl 2):S8–S11. doi: 10.1016/j.jcot.2018.04.016

Rare case of atypical femoral fracture with blocked medullary canal associated with bisphosphonate therapy

A Shetty 1,, P Shenoy 1, A Bari 1, R Swaminathan 1
PMCID: PMC6008637  PMID: 29928095

Abstract

Bisphosphonates are widely used for treatment of osteoporosis and its use is increasing in geriatric population.

Atypical femoral fractures are associated with bisphosphonate therapy.

We report an unusual case of femoral shaft fracture following bisphosphonate therapy where the femoral canal of the proximal and distal fracture fragments was blocked and its management.

Keywords: Osteoporosis, Geriatric, Bisphosphonates

1. Case report

76 year old woman of Asian origin was admitted with a short oblique fracture of mid shaft femur following a fall at home, she was on Alendronate for more than 5 years for treatment of osteoporosis, she had symptoms of thigh pain for weeks prior to fall. On examination it was found that the limb was deformed with no distal vascular deficit, she was splinted in a Thomas splint and was listed for cephalomedullary nail.

Radiographs revealed thickening of cortices, with blunt fracture ends typical fracture pattern in patients on bisphosphonates (Fig. 1).

Fig. 1.

Fig. 1

(a) and (b) Radiographs showing transverse fracture of midshaft of femur.

During fixation with cephalo medullary nail It was not possible to pass the guide wire beyond the distal end of the proximal fracture fragment, we realized the canal was blocked and tried reaming the proximal fragment to clear without success, we tried reaming with end cutting reamer as well without success, we tried tapping the guide wire with mallet to clear the block in the process she had comminution of the distal end of the proximal fracture fragment. We should have had a low threshold for open reduction and reaming and could have prevented the comminution (Fig. 2).

Fig. 2.

Fig. 2

(a) and (b) Intra operative pictures showing guide wire and reamer unable to penetrate proximal fragment.

We were unable to negate the guide wire through the distal fragment and had to open the fracture site and found even the distal fragment medullary canal was obliterated, the fragment had to be drilled with 3.2 mm guide pin and guide wire was passed through the fragments and each fragment reamed separately (Fig. 3).

Fig. 3.

Fig. 3

(a) and (b) Intra op pictures showing blocked canal of distal fragment drilled with 3.2 mm guide wire and cannulated awl passed over it to clear the block.

Post operative period was uneventful and she was subsequently discharged to rehabilitation unit with full weight bearing with crutches under the supervision of physiotherapists. At one year following the operation the fracture had healed and patient had no symptoms in the contralateral limb and radiographs of the contralateral femur showed no radiological changes (Fig. 4, Fig. 5).

Fig. 4.

Fig. 4

(a)–(c) 2 weeks’ post op radiographs showing cephalomedullary nail with early callus formation.

Fig. 5.

Fig. 5

One year post op showing fracture completely healed with callus formation.

2. Discussion

Osteoporosis is characterized by low bone mass and micro architectural deterioration of bone tissue leading to enhanced bone fragility subsequently increasing fracture risk. Bisphosphonates are frequently used in the treatment in osteoporosis, and their use is increasing widely in geriatric population, It increases bone mass and reduce the risk of fragility fracture, however there use over long periods can cause atypical femoral fractures as it inhibits the osteoclastic activity and suppresses the overall bone turnover.

Odvina et al. in 2005, first reported bisphosphonate related femoral fractures, since then there are numerous case reports of atypical femoral fractures related to bisphosphonates.3

Atypical femoral fractures (AFF) are essentially stress fracture arising at the tensile surface (Lateral aspect) of the femur, the fracture is transverse in orientation and as it reaches medially it can become oblique.6

Atypical features are characterized by lateral cortical beaking, diaphyseal cortical thickening, or a dreaded black line with prodromal pain in patients and associated with minimal or no trauma.

The patients may present with incomplete or complete fractures, clinical symptoms include prodromal thigh pain, and acute pain with a history of prolonged thigh pain usually indicates completeness of the incomplete fracture.

This is now a well-recognized complication with incidence of up to 7%7 and task force of American society for bone and mineral research has come out with major and minor criteria associated with atypical femoral fractures.6

Lo Jc et al. in his study reported Women with atypical femur fracture tend to be younger, Asian and stress or complete fracture of the contralateral femur in 39.5%.2

Hence examination and imaging of the contralateral femur is recommended.

Prolonged treatment leads to uncoupling of the bone homeostasis with reduced osteoclastic activity making the bone brittle, hence the concept of drug holiday has been advocated as they have a long half-life and potential complications from its treatment can be minimized.

Following the diagnosis of AFF bisphosphonates should be discontinued.5

The absolute number of osteoporotic fractures prevented is far more than a minimal atypical femur fracture; benefits outweigh the risks.4

We came across only one case report of femoral canal obliteration secondary to prolonged alendronate use.1 With the ever-increasing use of bisphosphonates for osteoporosis surgeon should be aware of this rare occurrence of blocked intramedullary canal in sub trochanteric fractures associated with their treatment.

Compliance with ethical standards

Funding: There is no funding source.

Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent: Informed consent was obtained from all individual participants included in the study.

Conflicts of interest

The authors have none to declare.

References

  • 1.Lim C.T., Setiobudi T., Das De S. Femoral canal obliteration secondary to prolonged alendronate use: a case report. J Orthop Surg (Hong Kong) 2012;20(1):115–117. doi: 10.1177/230949901202000125. [DOI] [PubMed] [Google Scholar]
  • 2.Lo J.C., Huang S.Y., Lee G.A. Clinical correlates of atypical femoral fracture. Bone. 2012;51(1):181–184. doi: 10.1016/j.bone.2012.02.632. [DOI] [PubMed] [Google Scholar]
  • 3.Odvina C.V., Zerwekh J.E., Rao D.S. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90(3):1294–1301. doi: 10.1210/jc.2004-0952. [DOI] [PubMed] [Google Scholar]
  • 4.Schilcher J., Michaëlsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011;364(18):1728–1737. doi: 10.1056/NEJMoa1010650. [DOI] [PubMed] [Google Scholar]
  • 5.Shane E., Burr D., Abrahamsen B. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res: Off J Am Soc Bone Miner Res. 2014;29(1):1–23. doi: 10.1002/jbmr.1998. [DOI] [PubMed] [Google Scholar]
  • 6.Shane E., Burr D., Ebeling P.R. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral research. J Bone Miner Res. 2010;25(11):2267–2294. doi: 10.1002/jbmr.253. [DOI] [PubMed] [Google Scholar]
  • 7.Thompson R.N., Phillips J.R.A., McCauley S.H.J., Elliott J.R.M., Moran C.G. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Jt Surg Br Vol. 2012;94(3):385–390. doi: 10.1302/0301-620X.94B3.27999. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Orthopaedics and Trauma are provided here courtesy of Elsevier

RESOURCES